Actively Recruiting
Comparing Ketorolac and Triamcinolone Injections for Treating Basilar Thumb Arthritis in Adults Over 40
Led by Mayo Clinic · Updated on 2026-02-23
240
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are comparing two types of joint injections to treat symptoms of moderate to advanced basilar thumb arthritis, a common form of osteoarthritis affecting the thumb base. The study aims to evaluate the effects of ketorolac, a non-steroidal anti-inflammatory drug NSAID, versus triamcinolone, a corticosteroid, to find a potentially effective and affordable treatment option. This is a randomized, controlled clinical trial sponsored by Mayo Clinic focusing on improving symptom relief while considering cartilage preservation and treatment costs. Participants will receive one of two injections during an appointment scheduled within four weeks after their initial evaluation. One group will get a 1.0 mL injection containing 15 mg of ketorolac, and the other group will receive a 0.5 mL injection containing 20 mg of triamcinolone. These injections are given directly into the joint. The study compares these two treatments over time to assess their impact on arthritis symptoms. Throughout the study, participants will be assessed at the initial evaluation and then at 1 month, 3 months, 6 months, and 1 year after injection. Researchers will measure pain levels using the Visual Analogue Scale VAS as the primary outcome. Secondary measures include hand function questionnaires and strength tests of grip, apposition, and opposition. These evaluations help monitor symptom changes and treatment effects while ensuring participant safety and adherence throughout the year-long follow-up period.
CONDITIONS
Brief Title
NSAID Injection Versus Corticosteroid Injection for Basilar Thumb Arthritis
Research Team
L
Lindsey Hobbs
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here